Stocksigma LogoStocksigma Logo

Shukra Medtech Board Meeting Scheduled for 4th Nov'26 to Consider Q2 Results

Shukra Medtech Limited (formerly Shukra Pharmaceuticals Limited) has scheduled its Board of Directors meeting for 4th Nov'26 (rescheduled from 3rd Nov'26)

Shukra Medtech Board Meeting Scheduled for 4th Nov'26 to Consider Q2 Results

Shukra Pharmaceuticals Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

Shukra Medtech Board Meeting Scheduled for 4th Nov'26 to Consider Q2 Results Shukra Medtech Limited (formerly Shukra Pharmaceuticals Limited) has scheduled its Board of Directors meeting for 4th Nov'26 (rescheduled from 3rd Nov'26) at its registered office. The board will inter alia consider and approve the company's unaudited financial results for the second quarter and half year ended 30th Sep'26, alongside the Auditor's Limited Review Report.

Original exchange filing (PDF)

More announcements from Shukra Pharmaceuticals Ltd

  • Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
  • Media Release 路 05 Nov 2026
  • Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
  • Reg 32 路 05 Nov 2026
  • Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
  • Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
  • SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
  • SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026

All Shukra Pharmaceuticals Ltd announcements